Show simple item record

Identification and Management of Hepatitis C Patients in Primary Care Clinics

dc.contributor.authorShehab, Thomas M.en_US
dc.contributor.authorOrrego, Mauricioen_US
dc.contributor.authorChunduri, Renuen_US
dc.contributor.authorLok, Anna Suk-Fongen_US
dc.date.accessioned2010-06-01T22:37:59Z
dc.date.available2010-06-01T22:37:59Z
dc.date.issued2003-03en_US
dc.identifier.citationShehab, Thomas M . ; Orrego, Mauricio; Chunduri, Renu; Lok, Anna S.F . (2003). "Identification and Management of Hepatitis C Patients in Primary Care Clinics." The American Journal of Gastroenterology 98(3): 639-644. <http://hdl.handle.net/2027.42/75608>en_US
dc.identifier.issn0002-9270en_US
dc.identifier.issn1572-0241en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/75608
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12650800&dopt=citationen_US
dc.description.abstractPrevious survey-based research suggested that hepatitis C patients receive suboptimal care in primary care settings. The aim of our study was to define the actual level of care hepatitis C patients receive in primary care clinics. Methods Medical records of 229 hepatitis C antibody-positive (group 1), 229 hepatitis C antibody-negative (group 2), and 229 patients not tested for hepatitis C antibody (group 3) were reviewed to assess the indications for hepatitis C testing and the subsequent management and referral of hepatitis C antibody-positive patients diagnosed in primary care clinics. In addition, the compliance of primary care physicians with hepatitis C screening and testing guidelines was assessed. Results Only 16 of group 1 and 10 of group 2 patients were tested for hepatitis C based on physician-identified risk factors. Only 1 of group 3 patients had documented discussion of hepatitis C risk factors during their initial visit with a primary care physician. The majority of hepatitis C antibody-positive patients was appropriately evaluated in primary care clinics, and most (77 ) hepatitis C RNA-positive patients with elevated liver enzymes were referred for subspecialty care. Of the 59 patients who underwent liver biopsy, 40 had bridging fibrosis or cirrhosis. Conclusions Hepatitis C testing is rarely initiated in primary care clinics based on physician-identified risk factors. Interventions should be developed to optimize early diagnosis of hepatitis C as significant liver disease may be present despite the absence of symptoms.en_US
dc.format.extent178673 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2003 by Am. Coll. of Gastroenterologyen_US
dc.titleIdentification and Management of Hepatitis C Patients in Primary Care Clinicsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDivisions of Gastroenterology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USAen_US
dc.contributor.affiliationumDivision ofGeneral Internal Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid12650800en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/75608/1/j.1572-0241.2003.07331.x.pdf
dc.identifier.doi10.1111/j.1572-0241.2003.07331.xen_US
dc.identifier.sourceThe American Journal of Gastroenterologyen_US
dc.identifier.citedreferenceAlter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556 562.en_US
dc.identifier.citedreferencePowell DW, for the Hepatitis C Consensus Development Panel National Institutes of Health consensus development conference panel statement: Management of hepatitis C. Hepatology 1997; 26 ( suppl 1 ): 2S 10S.en_US
dc.identifier.citedreferenceWong JB, McQuillan GM, McHutchinson JG, Poynard T. Estimating future hepatitis C morbidity, mortality and costs in the United States. Am J Public Health 2000; 90: 1562 1569.en_US
dc.identifier.citedreferenceWiley TE, McCarthy M, Breidi L, et al. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805 809.en_US
dc.identifier.citedreference5. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998; 47: 1 39.en_US
dc.identifier.citedreferenceManns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared to interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C: 24-week treatment analysis of a multicenter, multinational phase III randomized controlled trial. Hepatology 2000; 32: 552A ( abstract ).en_US
dc.identifier.citedreferenceFried MW, Shiffman ML, Reddy KR, et al. Pegylated (40 kDa) interferon alfa-2a (Pegasys) in combination with ribavirin: Efficacy and safety results from a Phase III, randomized, actively controlled, multicenter study. Gastroenterology 2001; 120 suppl 1: 289A ( abstract ).en_US
dc.identifier.citedreferenceMcHutchison JG, Gordon SC, Schiff ER, et al. Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485 1492.en_US
dc.identifier.citedreferencePoynard T, Marcellin P, Lee SS, et al. Randomized trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426 1432.en_US
dc.identifier.citedreferenceShehab TM, Sonnad SS, Jeffries M, et al. Current practice patterns of primary care physicians in the management of patients with hepatitis C. Hepatology 1999; 30: 794 800.en_US
dc.identifier.citedreferenceNicklin DE, Schultz C, Brensinger CM, Wilson JP. Current care of hepatitis C patients by primary care physicians in an integrated delivery system. J Am Board Fam Pract 1999; 12: 427 435.en_US
dc.identifier.citedreferenceShehab TM, Sonnad S, Lok ASF. Management of hepatitis C patients by primary care physicians: A nationwide survey. Hepatology 1999; 30: 209A ( abstract ).en_US
dc.identifier.citedreferenceHealey CJ, Chapmann RWG, Fleming K. Liver histology in hepatitis C infection: A comparison between patients with persistently normal and abnormal transaminase. Gut 1995; 37: 274 278.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.